Finance

Roʻyxatlar
CSPCY:OTCMKTS
CSPC Pharmaceuticals Group ADR
5,03 US$
+0,60%
(+0,030) 1K
6-okt, 16:00:00 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
CSPCY tikeri uchun statistika yaratilmoqda...
Ochish
4,91 US$
Yuqori
5,04 US$
Past
4,91 US$
Bozor kapitali
115,17 mlrd
Oʻrtacha hajm
1,40 ming
Hajmi
6,29 ming
52 haftalik eng yuqori
5,46 US$
52 haftalik eng past
3,26 US$
Beta
0,37
Muomaladagi aksiyalar
2,88 mlrd
Xodimlar soni
19 ming
Ochish
4,91 US$
Yuqori
5,04 US$
Past
4,91 US$
Bozor kapitali
115,17 mlrd
Oʻrtacha hajm
1,40 ming
Hajmi
6,29 ming
52 haftalik eng yuqori
5,46 US$
52 haftalik eng past
3,26 US$
Beta
0,37
Muomaladagi aksiyalar
2,88 mlrd
Xodimlar soni
19 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province. CSPC produces both active pharmaceutical ingredient and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products. CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP. CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion. CSPC Pharma is recognized as one of China's "500 Most Valuable Chinese Brands" and "Top 500 Chinese Enterprises." Wikipedia
CSPC Pharmaceuticals Group ADR haqida
CEOZhang Cuilong
Xodimlar soni18,6 ming
Asos solingan1992
Bosh ofislar-
Sektor-
Veb-saytcspc.com.hk
Avvalgi hisobotlarBarcha qiymatlar – HKD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – CNY
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
6,62 mlrd
6,11 mlrd
6,47 mlrd
12,13 mlrd
Sotilgan mahsulotning tannarxi
2,28 mlrd
2,11 mlrd
2,20 mlrd
2,24 mlrd
Daromad narxi
2,28 mlrd
2,11 mlrd
2,20 mlrd
2,24 mlrd
Tadqiqot va ishlanmalarga xarajatlar
1,50 mlrd
1,62 mlrd
1,40 mlrd
1,63 mlrd
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
1,97 mlrd
1,87 mlrd
1,89 mlrd
1,89 mlrd
Operatsion xarajatlar
3,47 mlrd
3,49 mlrd
3,29 mlrd
3,51 mlrd
Jami operatsion xarajatlar
5,75 mlrd
5,60 mlrd
5,49 mlrd
5,75 mlrd
Operatsion daromad
869,63 mln
514,71 mln
973,82 mln
6,38 mlrd
Boshqa nooperatsion daromad
645,14 mln
-470,42 mln
181,80 mln
11,92 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
1,18 mlrd
505,59 mln
1,13 mlrd
6,40 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
1,37 mlrd
186,56 mln
1,13 mlrd
6,35 mlrd
Daromad soligʻi boʻyicha xarajat
222,47 mln
165,64 mln
243,25 mln
825,70 mln
Amaldagi soliq stavkasi
18,78%
32,76%
21,46%
12,91%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
963,54 mln
370,72 mln
859,79 mln
5,23 mlrd
Sof foyda marjasi
14,56%
6,06%
13,30%
43,16%
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
-
195,87 mln
-
91,68 mln
Foizlarni toʻlash xarajatlari
-104,94 mln
-6,76 mln
-11,01 mln
-2,30 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-104,94 mln
189,12 mln
-11,01 mln
89,37 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
1,14 mlrd
802,06 mln
1,26 mlrd
6,67 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari